James Wassil
Chief Operating Officer presso VAXCYTE, INC.
Patrimonio netto: 15 M $ in data 31/03/2024
Posizioni attive di James Wassil
Società | Posizione | Inizio | Fine |
---|---|---|---|
VAXCYTE, INC. | Chief Operating Officer | 01/12/2019 | - |
Storia della carriera di James Wassil
Precedenti posizioni note di James Wassil
Società | Posizione | Inizio | Fine |
---|---|---|---|
ICOSAVAX, INC. | Director/Board Member | 01/06/2022 | 19/02/2024 |
Independent Dir/Board Member | 01/06/2022 | 19/02/2024 | |
PFIZER, INC. | Corporate Officer/Principal | 01/05/2015 | 01/12/2019 |
NOVARTIS AG | Corporate Officer/Principal | 01/08/2008 | 01/05/2015 |
Infectious Diseases Society of America
Infectious Diseases Society of America Miscellaneous Commercial ServicesCommercial Services The Infectious Diseases Society of America is a non-profit company that provides clinical practice guidelines development and guideline panelists for infectious diseases. The company is based in Arlington, VA and has subsidiaries in the United States. The company specializes in antimicrobial stewardship and have established Antimicrobial Stewardship Centers of Excellence. The CEO of the company is Christopher Busky. | Corporate Officer/Principal | - | - |
MERCK & CO., INC. | Sales & Marketing | - | - |
Formazione di James Wassil
University of Notre Dame | Undergraduate Degree |
Lehigh University | Graduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 8 |
Svizzera | 2 |
Posizioni
Corporate Officer/Principal | 3 |
Chief Operating Officer | 1 |
Sales & Marketing | 1 |
Settori
Health Technology | 6 |
Consumer Services | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 4 |
---|---|
MERCK & CO., INC. | Health Technology |
PFIZER, INC. | Health Technology |
NOVARTIS AG | Health Technology |
VAXCYTE, INC. | Health Technology |
Aziende private | 2 |
---|---|
Infectious Diseases Society of America
Infectious Diseases Society of America Miscellaneous Commercial ServicesCommercial Services The Infectious Diseases Society of America is a non-profit company that provides clinical practice guidelines development and guideline panelists for infectious diseases. The company is based in Arlington, VA and has subsidiaries in the United States. The company specializes in antimicrobial stewardship and have established Antimicrobial Stewardship Centers of Excellence. The CEO of the company is Christopher Busky. | Commercial Services |
Icosavax, Inc.
Icosavax, Inc. Pharmaceuticals: MajorHealth Technology Icosavax, Inc. engages in the development and commercialization of vaccines against infectious diseases. It focuses on developing vaccine candidates for viral causes of pneumonia in older adults. The company was founded by Neil King and David Baker on November 1, 2017 and is headquartered in Seattle, WA. | Health Technology |
- Borsa valori
- Insiders
- James Wassil
- Esperienza